View ValuationCalifornia Nanotechnologies 将来の成長Future 基準チェック /06California Nanotechnologiesは、20.7%と10.7%でそれぞれ年率20.7%で利益と収益が成長すると予測される一方、EPSはgrowで31.1%年率。主要情報20.7%収益成長率31.14%EPS成長率Machinery 収益成長16.7%収益成長率10.7%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日03 Feb 2026今後の成長に関する最新情報お知らせ • Sep 14California Nanotechnologies Corp. Provides Earnings Guidance for the Ended August 31, 2023California Nanotechnologies Corp. provided earnings guidance for the ended August 31, 2023. The company's revenues of approximately USD 675,000 are expected for the second quarter ended August 31, 2023. This is expected to represent another quarterly revenue record and a 148% increase over second quarter 2023 revenues of USD 271,969. The Company preliminary estimated net income of approximately USD 175,000 compared to a net loss of USD 26,496 for the same period last year.すべての更新を表示Recent updatesお知らせ • Mar 24California Nanotechnologies Corp. announced that it has received CAD 0.9359 million in fundingOn March 23, 2026, the California Nanotechnologies Corp closed the transaction. In connection with the Offering, the Company has agreed to pay a cash commission in the aggregate of CAD 1,131.08 ($825) and to issue an aggregate of 154,179 common shares. A certain director of the Company subscribed for an aggregate of 500,000 Units under the Offering,お知らせ • Feb 25California Nanotechnologies Corp. announced that it expects to receive CAD 0.75 million in fundingCalifornia Nanotechnologies Corp announced a non-brokered private placement to issue 2,500,000 units at an issue price of CAD 0.30 for the proceeds of CAD 750,000 on February 24, 2026. Each Unit will be comprised of one common share and one Common Share purchase warrant. Each Warrant shall be exercisable to acquire one additional Common Share at an exercise price of CAD 0.41 ($0.30) for eighteen (18) months from the closing of the Offering. The Offering is subject to an over-allotment option allowing the Company to increase the Units sold by an additional 1,000,000 Units for additional proceeds of CAD 300,000, if fully exercised. The Offering is subject to the receipt of all necessary regulatory and other approvals, including the receipt of approval from the TSX Venture Exchange (the “TSXV”). Finder’s fees may be payable in connection with the Offering. Certain insiders of the Company may acquire securities under the Offering.お知らせ • Aug 25California Nanotechnologies Corp., Annual General Meeting, Oct 24, 2025California Nanotechnologies Corp., Annual General Meeting, Oct 24, 2025.お知らせ • Aug 20California Nanotechnologies Corp., Annual General Meeting, Oct 24, 2024California Nanotechnologies Corp., Annual General Meeting, Oct 24, 2024.お知らせ • Oct 31California Nanotechnologies Corp. announced that it has received CAD 1.5 million in fundingOn October 30, 2023, California Nanotechnologies Corp. closed the transaction. The company sold 10,000,000 Units which included full exercise of the over-allotment option, at a price of CAD 0.15 per Unit for the gross proceeds of CAD 1,500,000. Each Unit consists of one common share and one half of one Common Share purchase warrant. Each Warrant shall entitle the holder to acquire one additional Common Share at an exercise price of CAD 0.25 at any time on or before October 30, 2025. The Offering is subject to the receipt of all necessary regulatory and other approvals,including the receipt of final approval from the TSX Venture Exchange (the “TSXV”). Finder’s fees in the aggregate cash amount of CAD 22,673.50, equivalent to 5.5% of the gross proceeds of certain subscriptions under the Offering, were paid to eligible finders. No finder’s warrants or similar securities were issued in connection with the Offering. Eric Eyerman, Roger Dent, and Sebastien Goulet purchased an aggregate of 3,586,666 Units under the Offering, representing approximately 35.9% of the Offering.お知らせ • Sep 15California Nanotechnologies Corp. announced that it expects to receive CAD 1.25 million in fundingCalifornia Nanotechnologies Corp has announced a non-brokered private placement of up to 8,333,333 units at a price of CAD 0.15 per Unit for total gross proceeds to the company of up to CAD 1,250,000 on September 14, 2023. The transaction included participation from Certain insiders and Eric Eyerman, Chief Executive Officer of the Company is also expected to participate in the Offering by purchasing 2,250,000 units at a price of CAD 0.15 per Unit for aggregate gross proceeds of CAD 333,333. Certain insiders of the Company may acquire securities under the Offering, with the expected Insider participation being at least 25% of the Offering. The transaction is subject to an over-allotment option allowing the company to increase the units sold by an additional 1,666,667 Units for additional proceeds of CAD 250,000, if fully exercised. Each Unit will be comprised of one common share in the capital of the Company and one half of one Common Share purchase warrant. Each Warrant shall be exercisable to acquire one additional Common Share at an exercise price of CAD 0.25 for two years from the closing of the Offering. The transaction is subject to the receipt of all necessary regulatory and other approvals, including the receipt of approval from the TSX Venture Exchange. The securities are expected to be immediately freely tradeable under applicable Canadian securities legislation if sold to purchasers resident in Canada, other than securities acquired by insiders which shall be subject to a hold period of four months pursuant to TSXV policies.お知らせ • Sep 14California Nanotechnologies Corp. Provides Earnings Guidance for the Ended August 31, 2023California Nanotechnologies Corp. provided earnings guidance for the ended August 31, 2023. The company's revenues of approximately USD 675,000 are expected for the second quarter ended August 31, 2023. This is expected to represent another quarterly revenue record and a 148% increase over second quarter 2023 revenues of USD 271,969. The Company preliminary estimated net income of approximately USD 175,000 compared to a net loss of USD 26,496 for the same period last year.お知らせ • Jun 24California Nanotechnologies Corp., Annual General Meeting, Aug 23, 2023California Nanotechnologies Corp., Annual General Meeting, Aug 23, 2023.業績と収益の成長予測OTCPK:CANO.F - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数2/29/20284-10012/28/20272-2-1-112/28/20263-200111/30/20253-200N/A8/31/20254-102N/A5/31/20255-113N/A2/28/20256013N/A11/30/20246002N/A8/31/20245001N/A5/31/20245100N/A2/29/20243000N/A11/30/20233100N/A8/31/20232000N/A5/31/20232000N/A2/28/20231011N/A11/30/20221011N/A8/31/20221000N/A5/31/20221000N/A2/28/20221000N/A11/30/20211000N/A8/31/20211000N/A5/31/20211000N/A2/28/20211000N/A11/30/20201000N/A8/31/20201000N/A5/31/20201000N/A2/29/20201000N/A11/30/20191000N/A8/31/201910N/A0N/A5/31/201910N/A0N/A2/28/201910N/A0N/A11/30/201810N/A0N/A8/31/201810N/A0N/A5/31/201810N/A0N/A2/28/201810N/A0N/A11/30/201700N/A0N/A8/31/201710N/A0N/A5/31/201710N/A0N/A2/28/201710N/A0N/A11/30/201610N/A0N/A8/31/201600N/A0N/A5/31/201600N/A0N/A2/29/201600N/A0N/A11/30/201500N/A0N/A8/31/201500N/A0N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: CANO.F今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: CANO.F今後 3 年間、利益が出ない状態が続くと予測されています。高成長収益: CANO.F今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: CANO.Fの収益 ( 10.7% ) US市場 ( 12.6% ) よりも低い成長が予測されています。高い収益成長: CANO.Fの収益 ( 10.7% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: CANO.Fの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YCapital-goods 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/29 18:05終値2026/06/26 00:00収益2025/11/30年間収益2025/02/28データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋California Nanotechnologies Corp. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Tate SullivanMaxim Group
お知らせ • Sep 14California Nanotechnologies Corp. Provides Earnings Guidance for the Ended August 31, 2023California Nanotechnologies Corp. provided earnings guidance for the ended August 31, 2023. The company's revenues of approximately USD 675,000 are expected for the second quarter ended August 31, 2023. This is expected to represent another quarterly revenue record and a 148% increase over second quarter 2023 revenues of USD 271,969. The Company preliminary estimated net income of approximately USD 175,000 compared to a net loss of USD 26,496 for the same period last year.
お知らせ • Mar 24California Nanotechnologies Corp. announced that it has received CAD 0.9359 million in fundingOn March 23, 2026, the California Nanotechnologies Corp closed the transaction. In connection with the Offering, the Company has agreed to pay a cash commission in the aggregate of CAD 1,131.08 ($825) and to issue an aggregate of 154,179 common shares. A certain director of the Company subscribed for an aggregate of 500,000 Units under the Offering,
お知らせ • Feb 25California Nanotechnologies Corp. announced that it expects to receive CAD 0.75 million in fundingCalifornia Nanotechnologies Corp announced a non-brokered private placement to issue 2,500,000 units at an issue price of CAD 0.30 for the proceeds of CAD 750,000 on February 24, 2026. Each Unit will be comprised of one common share and one Common Share purchase warrant. Each Warrant shall be exercisable to acquire one additional Common Share at an exercise price of CAD 0.41 ($0.30) for eighteen (18) months from the closing of the Offering. The Offering is subject to an over-allotment option allowing the Company to increase the Units sold by an additional 1,000,000 Units for additional proceeds of CAD 300,000, if fully exercised. The Offering is subject to the receipt of all necessary regulatory and other approvals, including the receipt of approval from the TSX Venture Exchange (the “TSXV”). Finder’s fees may be payable in connection with the Offering. Certain insiders of the Company may acquire securities under the Offering.
お知らせ • Aug 25California Nanotechnologies Corp., Annual General Meeting, Oct 24, 2025California Nanotechnologies Corp., Annual General Meeting, Oct 24, 2025.
お知らせ • Aug 20California Nanotechnologies Corp., Annual General Meeting, Oct 24, 2024California Nanotechnologies Corp., Annual General Meeting, Oct 24, 2024.
お知らせ • Oct 31California Nanotechnologies Corp. announced that it has received CAD 1.5 million in fundingOn October 30, 2023, California Nanotechnologies Corp. closed the transaction. The company sold 10,000,000 Units which included full exercise of the over-allotment option, at a price of CAD 0.15 per Unit for the gross proceeds of CAD 1,500,000. Each Unit consists of one common share and one half of one Common Share purchase warrant. Each Warrant shall entitle the holder to acquire one additional Common Share at an exercise price of CAD 0.25 at any time on or before October 30, 2025. The Offering is subject to the receipt of all necessary regulatory and other approvals,including the receipt of final approval from the TSX Venture Exchange (the “TSXV”). Finder’s fees in the aggregate cash amount of CAD 22,673.50, equivalent to 5.5% of the gross proceeds of certain subscriptions under the Offering, were paid to eligible finders. No finder’s warrants or similar securities were issued in connection with the Offering. Eric Eyerman, Roger Dent, and Sebastien Goulet purchased an aggregate of 3,586,666 Units under the Offering, representing approximately 35.9% of the Offering.
お知らせ • Sep 15California Nanotechnologies Corp. announced that it expects to receive CAD 1.25 million in fundingCalifornia Nanotechnologies Corp has announced a non-brokered private placement of up to 8,333,333 units at a price of CAD 0.15 per Unit for total gross proceeds to the company of up to CAD 1,250,000 on September 14, 2023. The transaction included participation from Certain insiders and Eric Eyerman, Chief Executive Officer of the Company is also expected to participate in the Offering by purchasing 2,250,000 units at a price of CAD 0.15 per Unit for aggregate gross proceeds of CAD 333,333. Certain insiders of the Company may acquire securities under the Offering, with the expected Insider participation being at least 25% of the Offering. The transaction is subject to an over-allotment option allowing the company to increase the units sold by an additional 1,666,667 Units for additional proceeds of CAD 250,000, if fully exercised. Each Unit will be comprised of one common share in the capital of the Company and one half of one Common Share purchase warrant. Each Warrant shall be exercisable to acquire one additional Common Share at an exercise price of CAD 0.25 for two years from the closing of the Offering. The transaction is subject to the receipt of all necessary regulatory and other approvals, including the receipt of approval from the TSX Venture Exchange. The securities are expected to be immediately freely tradeable under applicable Canadian securities legislation if sold to purchasers resident in Canada, other than securities acquired by insiders which shall be subject to a hold period of four months pursuant to TSXV policies.
お知らせ • Sep 14California Nanotechnologies Corp. Provides Earnings Guidance for the Ended August 31, 2023California Nanotechnologies Corp. provided earnings guidance for the ended August 31, 2023. The company's revenues of approximately USD 675,000 are expected for the second quarter ended August 31, 2023. This is expected to represent another quarterly revenue record and a 148% increase over second quarter 2023 revenues of USD 271,969. The Company preliminary estimated net income of approximately USD 175,000 compared to a net loss of USD 26,496 for the same period last year.
お知らせ • Jun 24California Nanotechnologies Corp., Annual General Meeting, Aug 23, 2023California Nanotechnologies Corp., Annual General Meeting, Aug 23, 2023.